Evidencias recientes amplan las acciones cardioprotectoras de GLP-1 a condiciones patolgicas diferentes del IM o de la IC
Applicable Procedure Code: J3241
doi: 10.1001/jama.2016.0287 Summary Keywords GLP-1 - glucagon-like peptide-1, incretin, GLP-1 agonists, hormone, inflammation, anti-inflammation Citation Mehdi SF, Pusapati S, Anwar MS, Lohana D, Kumar P, Nandula SA, Nawaz FK, Tracey K, Yang H, LeRoith D, Brownstein MJ and Roth J (2023) Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent
This claim is based on the results of clinical trials that evaluated the effects of the weight loss medications offered through the Ro Body Program, including Zepbound (tirzepatide) and Wegovy (semaglutide)
It also promotes sun tanning, forms freckles and age spots, and causes uneven pigment in some people